so @shlok, as you clearly seem to be so well- informed - how will it be revised to accommodate dimx? Which part(s) / box(es)? You reckon it’ll wipe out corticosteroids or calcineurin inhibitors in those presenting with FSg and nephrotic syndrome ?
Ann: Investor Presentation, page-105
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.045(11.5%) |
Mkt cap ! $239.5M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 44.0¢ | 40.0¢ | $2.225M | 5.387M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11627 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 126213 | 4 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |